Strange: Bullish ASND Analysts Actually See -7.03% Downside
March 22, 2018 at 10:06 AM EDT
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Ascendis Pharma A/S (ASND). The average 12-month price target for ASND averaging the work of 5 analysts reveals an average price target of $61.40/share..